Table 2.

Summary of the most important variables to predict GVHD and NRM in univariate analysis

VariablePolymorphismD/ROR*
aGVHD 2-4aGVHD 3-4cGVHDExtensive cGVHDNRM
Clinical        
 Recipient age >45 y      
 Recipient sex, male vs female       
 Female donor/male recipient       
 MDS       
 Conditioning, RIC vs MAC      
 Conditioning regimen, no TBI vs TBI       
 Stem-cell source, PB vs BM      
 aGVHD, grade 2-4      
Genetic        
 IL-1A rs1800587     
 IL-1B rs1143627     
      
 rs16944     
      
 rs1143634     
      
 IL-2 rs2069762     
 IL-6 rs1800795     
 IL-17A rs8193036     
 rs4711998    
      
 rs2275913     
 rs3819024     
      
 IL-23R rs6687620    
      
 rs11209026     
 TGFβ rs1800469     
 INF-γ rs2069705     
VariablePolymorphismD/ROR*
aGVHD 2-4aGVHD 3-4cGVHDExtensive cGVHDNRM
Clinical        
 Recipient age >45 y      
 Recipient sex, male vs female       
 Female donor/male recipient       
 MDS       
 Conditioning, RIC vs MAC      
 Conditioning regimen, no TBI vs TBI       
 Stem-cell source, PB vs BM      
 aGVHD, grade 2-4      
Genetic        
 IL-1A rs1800587     
 IL-1B rs1143627     
      
 rs16944     
      
 rs1143634     
      
 IL-2 rs2069762     
 IL-6 rs1800795     
 IL-17A rs8193036     
 rs4711998    
      
 rs2275913     
 rs3819024     
      
 IL-23R rs6687620    
      
 rs11209026     
 TGFβ rs1800469     
 INF-γ rs2069705     

All variables are statistically significant (P < .05).

BM, bone marrow; D, donor; H, higher risk; L, lower risk; MAC, myeloablative conditioning; OR, odds ratio; PB, peripheral blood; R, recipient; RIC, reduced-intensity conditioning.

*

OR = 1 (neutral); OR < 1 (L); OR > 1 (H).

Close Modal

or Create an Account

Close Modal
Close Modal